EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer Cells

Giulia Lori, Caterina Mancini iD, Caterina Paffetti, Dayana Desideri, Erica Pranzini iD, Alice Santi, Manuela Leri iD, Alessio Biagioni iD, Matteo Benelli, Pietro Spatafora iD, Fedele Maria Manicone, Flavia Sorbi iD und 5 weitere

Cells · 2026

DOI: 10.3390/cells15090770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Giulia Lori und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, Viale Morgagni 50, 50134 Florence, Italy. Hauptthemen laut MEDLINE: Glutamine, Ovarian Neoplasms, Stromal Cells, Prostatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro (AIRC), THE (Tuscany Health Ecosystem), Fondazione Umberto Veronesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer progression is influenced by the dynamic interplay between tumor cells and the surrounding stromal microenvironment. Therapy-induced senescence (TIS) of stromal fibroblasts represents a common outcome of anticancer treatments, contributing to tumor progression through the senescence-associated secretory phenotype (SASP). While SASP cytokines promote cancer malignancy, the contribution of secreted metabolites from senescent cells remains poorly understood. Here, we investigate the role of senescent stromal metabolism in regulating prostate and ovarian cancer cell invasion. Conditioned media (CM) from TIS-induced human prostate (HPFs) and ovarian fibroblasts (HOFs) promote enhanced invasion of cancer cells. Invasion is partially preserved after exposure to boiled CM, suggesting a role for heat-stable metabolic factors. Metabolomic profiling of senescent fibroblasts-derived CM reveals a significant increase in Glutamine (Gln) levels, identifying senescent stromal fibroblasts as a previously unrecognized source of extracellular Gln in the tumor microenvironment (TME). Exposure of cancer cells to senescent CM increases Gln uptake, together with upregulation of the transporter SLC1A5 and increased intracellular Gln. This metabolic adaptation is associated with increased malignant phenotype including epithelial-to-mesenchymal transition (EMT) and stemness features. Extracellular Gln depletion, pharmacological inhibition of glutaminase-1 (GLS1) in cancer cells, or Gln synthetase (GS) silencing in fibroblasts markedly impair senescent fibroblasts CM-induced invasion, EMT markers expression, and stemness features in cancer cells. Stromal-derived Gln is associated with increased cancer cell invasion through activation of a redox-dependent NRF2/ETS1 signaling axis. Analysis of patient-derived transcriptomic datasets further suggests chemotherapy-associated upregulation of Gln metabolism and ETS1 expression. These findings identify senescent stromal-derived Gln as a key metabolic driver of prostate and ovarian cancer aggressiveness and reveal a TIS-associated metabolic vulnerability that could be explored in future preclinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlutamineOvarian NeoplasmsStromal CellsProstatic NeoplasmsCellular SenescenceHumansFemaleMaleTumor MicroenvironmentCell Line, TumorCulture Media, ConditionedFibroblastsAmino Acid Transport System ASCNeoplasm InvasivenessMinor Histocompatibility AntigensEpithelial-Mesenchymal TransitionSenescence-Associated Secretory PhenotypeNF-E2-Related Factor 2

Stichwörter der Autor:innen

NRF2/ETS1 signalingcancer cell invasionfibroblastsglutamine metabolismtherapy-induced senescence

Substanzen

GlutamineSLC1A5 protein, humanCulture Media, ConditionedAmino Acid Transport System ASCMinor Histocompatibility AntigensNF-E2-Related Factor 2NFE2L2 protein, human

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
  • Department of Experimental and Clinical Biomedical Sciences-"Mario Serio", University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
  • Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, Careggi Hospital University of Florence, 50134 Florence, Italy.
  • Careggi University Hospital, University of Florence, 50134 Florence, Italy.

ORCID-Profile: Caterina Mancini, Erica Pranzini, Manuela Leri, Alessio Biagioni, Pietro Spatafora, Flavia Sorbi, Sergio Serni, Francesca Magherini, Maria Letizia Taddei

Förderung

  • Associazione Italiana per la Ricerca sul Cancro (AIRC)
  • THE (Tuscany Health Ecosystem)
  • Fondazione Umberto Veronesi

Zitieren

APA

Lori, G., Mancini, C., Paffetti, C., Desideri, D., Pranzini, E., Santi, A., Leri, M., Biagioni, A., Benelli, M., Spatafora, P., Manicone, F. M., Sorbi, F., Leo, A., Fambrini, M., Serni, S., Magherini, F., & Taddei, M. L. (2026). Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer Cells. Cells. https://doi.org/10.3390/cells15090770

Vancouver

Lori G, Mancini C, Paffetti C, Desideri D, Pranzini E, Santi A, et al. Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer Cells. Cells. 2026. doi:10.3390/cells15090770

BibTeX
@article{Lori2026,
  author = {Lori, Giulia and Mancini, Caterina and Paffetti, Caterina and Desideri, Dayana and Pranzini, Erica and Santi, Alice and Leri, Manuela and Biagioni, Alessio and Benelli, Matteo and Spatafora, Pietro and Manicone, Fedele Maria and Sorbi, Flavia and Leo, Angela and Fambrini, Massimiliano and Serni, Sergio and Magherini, Francesca and Taddei, Maria Letizia},
  title = {Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer Cells},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15090770}
}
Kostenlos starten →